所以FDA的文章裡寫出了三個型號的檢測試劑組
然後說明如下
Accula SARS-Cov-2 Test: ......
While the impact does not appear to be significant
TaqPath COVID-19 Combo Kit:........
Since this test is designed to detect multiple genetic targets, the overall test sensitivity should not be impacted.
Linea COVID-19 Assay Kit: ........
Since this test is designed to detect multiple genetic targets, the overall test sensitivity should not be impacted.
因為沒有哪個試劑組會只以單一的基因組作判別,所以實際上目前的變異病毒株還沒有哪個會如前面宣稱的"變種病毒準確率更低"
未來會不會有突變足以改變檢驗準確度的突變病毒,有可能會有,但是
現在就宣稱有?
